Get the Stockscreener App
0.6103
18.07%
0.0934
After Hours:
.59
-0.0203
-3.33%
Renovaro Inc stock is traded at $0.6103, with a volume of 601.14K.
It is up +18.07% in the last 24 hours and up +19.43% over the past month.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
See More
Previous Close:
$0.5169
Open:
$0.5169
24h Volume:
601.14K
Relative Volume:
1.33
Market Cap:
$91.21M
Revenue:
-
Net Income/Loss:
$-41.23M
P/E Ratio:
-0.8596
EPS:
-0.71
Net Cash Flow:
$-11.54M
1W Performance:
+21.14%
1M Performance:
+19.43%
6M Performance:
-57.02%
1Y Performance:
-82.21%
1-Day Range:
$0.5169
$0.62
1-Week Range:
$0.46
$0.62
52-Week Range:
$0.395
$5.25
Renovaro Inc Stock (RENB) Company Profile
Name
Renovaro Inc
Sector
Industry
Phone
45 39179840
Address
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare RENB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RENB
Renovaro Inc
|
0.6103 | 91.21M | 0 | -41.23M | -11.54M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
464.56 | 119.70B | 10.63B | -479.80M | -1.35B | 13.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.87 | 82.75B | 13.85B | 4.65B | 3.32B | 35.06 |
|
ARGX
Argen X Se Adr
|
614.59 | 36.73B | 1.86B | -40.29M | -1.28B | -4.16 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.74 | 32.53B | 2.09B | -332.26M | 16.06M | -4.14 |
|
BNTX
Biontech Se Adr
|
120.72 | 28.50B | 3.30B | -501.07M | 1.03B | 11.54 |
Renovaro Inc Stock (RENB) Latest News
Renovaro (NASDAQ:RENB) Trading Up 6.5%What's Next? - MarketBeat
Renovaro: Fiscal Q1 Earnings Snapshot - New Haven Register
Renovaro Inc. (RENB) Quarterly 10-Q Report - Quartzy
Renovaro Inc. revises CFO compensation package - Investing.com India
Renovaro Biosciences Appoints Simon Tarsh as Interim CFO - TipRanks
Renovaro Inc. revises CFO compensation package By Investing.com - Investing.com UK
Renovaro appoints new CEO to advance cancer tech By Investing.com - Investing.com Canada
Renovaro BioSciences issues shareholder letter - TipRanks
Renovaro appoints new CEO to advance cancer tech - Investing.com
Renovaro Issues Shareholder Letter and Provides Corporate Update - GlobeNewswire
Renovaro (NASDAQ:RENB) Trading Down 4%Should You Sell? - MarketBeat
Renovaro's William Anderson Wittekind sells shares worth $1,448 By Investing.com - Investing.com South Africa
Renovaro's William Anderson Wittekind sells shares worth $1,448 - Investing.com India
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing - GlobeNewswire
Renovaro Inc. reshuffles board, appoints new CEO - Investing.com India
Renovaro Inc appoints new CEO, revamps board - Investing.com
Powerful Leadership Transition to Optimize Highly Promising AI - openPR
Renovaro BioSciences announces strategic restructuring, leadership transition - TipRanks
Renovaro Inc. reshuffles board, appoints new CEO By Investing.com - Investing.com UK
Renovaro Names Weinstein as CEO; Four New Board Appointments - MarketWatch
Renovaro Inc appoints new CEO, revamps board By Investing.com - Investing.com UK
Renovaro Announces Strategic Restructuring and Leadership Transition - ForexTV.com
Renovaro Biosciences Appoints New CEO and Board Members - TipRanks
Renovaro Inc. (RENB)’s stock rises to 0.71 per share - US Post News
A Guide To The Risks Of Investing In Renovaro Inc. (RENB) - Knox Daily
Renovaro Inc. (RENB) Stock: A Year of Market Fluctuations - The InvestChronicle
DanDrit Biotech stock hits 52-week low at $0.41 - Investing.com
DanDrit Biotech stock hits 52-week low at $0.41 By Investing.com - Investing.com South Africa
Upward Trajectory: Renovaro Inc. (RENB) Posts a Slidee, Closing at 0.49 - The Dwinnex
Renovaro Inc. (RENB) can make a big difference with a little luck - SETE News
How does RENB’s price to cash per share ratio compare in the market? - US Post News
RENB’s 52-Week Rollercoaster: From $0.42 to $5.25 – What’s Next for Investors? - The InvestChronicle
Renovaro Biosciences soars after responding to Hindenburg short call - MSN
Another «earthquake« in MotoGP? Alberto Puig could be leaving Honda... to be replaced by Francesco Guidotti - Motorcycle Sports
Grab appoints Ronald Roda as Grab Philippines country head - Malaya
Grab PH appoints new country head - The Manila Times
Grab names new Philippines country head - Philstar.com
Grab names Roda as PH country head - manilastandard.net
Grab PH names new country head - pna.gov.ph
Ronald Roda is Grab PH’s new country head as Grace Vera Cruz moves to regional role - MARKETECH APAC
Ronald Roda set to drive growth at Grab Philippines as new Country Head - Bilyonaryo Business News
Grab Philippines announces new country head - GMA News Online
Ronald Roda steps in as new Grab Philippines country head - Backend News
Ensign Peak Advisors Inc Trims Holdings in Graco Inc. (NYSE:GGG) - Defense World
Honda Donates Life-Saving Generators to Power Communities - LionhearTV
MotoGP, the end of an era at Honda: Alberto Puig on the way out and Guidotti's break with KTM approaching - Paddock GP
Renovaro Inc Stock (RENB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Renovaro Inc Stock (RENB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| William Anderson Wittekind | 10% Owner |
Jul 17 '24 |
Sale |
1.46 |
16,362 |
23,889 |
841,433 |
| William Anderson Wittekind | 10% Owner |
Jul 15 '24 |
Sale |
1.41 |
21,954 |
30,955 |
875,795 |
| William Anderson Wittekind | 10% Owner |
Jul 10 '24 |
Sale |
1.51 |
75,000 |
113,250 |
894,645 |
| William Anderson Wittekind | 10% Owner |
Jul 11 '24 |
Sale |
1.51 |
14,896 |
22,493 |
897,749 |
| William Anderson Wittekind | 10% Owner |
Jul 09 '24 |
Sale |
1.53 |
4,630 |
7,084 |
969,645 |
| William Anderson Wittekind | 10% Owner |
Jul 05 '24 |
Sale |
1.55 |
60,000 |
93,000 |
974,275 |
| William Anderson Wittekind | 10% Owner |
Jul 03 '24 |
Sale |
1.51 |
50,000 |
75,500 |
1,034,275 |
| William Anderson Wittekind | 10% Owner |
Jul 01 '24 |
Sale |
1.56 |
60,000 |
93,600 |
1,118,828 |
| William Anderson Wittekind | 10% Owner |
Jul 02 '24 |
Sale |
1.54 |
34,553 |
53,212 |
1,084,275 |
| William Anderson Wittekind | 10% Owner |
Jun 26 '24 |
Sale |
1.57 |
50,000 |
78,500 |
1,193,499 |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):